|
Components
ACADIA Pharmaceuticals Inc. |
ACAD |
Agios Pharmaceuticals, Inc. |
AGIO |
Alkermes Plc |
ALKS |
Alnylam Pharmaceuticals, Inc. |
ALNY |
Amgen Inc. |
AMGN |
Biogen Inc. |
BIIB |
BioMarin Pharmaceutical Inc. |
BMRN |
BioNTech SE (ADR) |
BNTX |
Bio-Techne Corporation |
TECH |
Charles River Laboratories International, Inc. |
CRL |
Exact Sciences Corporation |
EXAS |
Exelixis, Inc. |
EXEL |
FibroGen, Inc. |
FGEN |
Gilead Sciences, Inc. |
GILD |
Grifols, S.A. (ADR) |
GRFS |
Illumina, Inc. |
ILMN |
Incyte Corporation |
INCY |
Ionis Pharmaceuticals, Inc. |
IONS |
IQVIA Holdings Inc. |
IQV |
Mettler-Toledo International Inc. |
MTD |
Moderna, Inc. |
MRNA |
Nektar Therapeutics |
NKTR |
Neurocrine Biosciences, Inc. |
NBIX |
QIAGEN N.V. |
QGEN |
Regeneron Pharmaceuticals, Inc. |
REGN |
Sarepta Therapeutics, Inc. |
SRPT |
Seagen Inc. |
SGEN |
Ultragenyx Pharmaceutical Inc. |
RARE |
United Therapeutics Corporation |
UTHR |
Vertex Pharmaceuticals Incorporated |
VRTX |
|
|
|
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|